Skip to main content
Premium Trial:

Request an Annual Quote

Carnegie Mellon, U of Pittsburgh to Offer Joint PhD in Computational Biology

NEW YORK, Sept. 15 (GenomeWeb News) - The University of Pittsburgh and CarnegieMellonUniversity said this week that they are launching a joint doctoral program in computational biology.

 

The new program has already accepted a "small number" of students to begin in fall 2005 and spring 2006 and will accept its first full class in fall 2006. The program is expected to reach a "steady enrollment" of 50 students.

 

The program will include "roughly equal numbers of faculty and students participating from both campuses," said Mark Kamlet, provost and senior vice president of Carnegie Mellon.

 

Robert Murphy, professor of biological sciences and biomedical engineering at Carnegie Mellon, and Ivet Bahar, professor and chairman of the department of computational biology at the University of Pittsburgh School of Medicine, will serve as co-directors of the PhD program.

 

Carnegie Mellon has offered a formal undergraduate degree program in computational biology since 1987 and began offering a master's degree in the field in 1999.

 

The University of Pittsburgh School of Medicine established its department of computational biology last year.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.